Contact
searchSearch
HMP Global

Psoriasis Topic Center

News
Comparing the Cost-Effectiveness of Phototherapy and Biologics for Psoriasis and Atopic Dermatitis Treatment
12/21/2023
Hannah Musick
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to...
12/21/2023
First Report Managed Care
News
High Rates of Therapy Switching Among Patients With Psoriasis Initiating Biologics
11/06/2023
Hannah Musick
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care
News
Mediterranean Diet Added to Standard Therapy Holds Benefit for Patients with Psoriasis
10/13/2023
Jolynn Tumolo
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care
News
AI Revolutionizing Psoriasis Severity Assessment for Precise Therapy and QoL Improvement
09/15/2023
Danielle Sposato
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of...
09/15/2023
First Report Managed Care
News
Secukinumab Well-Tolerated in Pediatric Patients With Plaque Psoriasis
08/29/2023
Jolynn Tumolo
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well...
08/29/2023
First Report Managed Care
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Jolynn Tumolo
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care
News
Global Survey Suggests Patients Have Loose Grasp of Psoriatic Disease
05/16/2023
Jolynn Tumolo
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to...
05/16/2023
First Report Managed Care
News
Three-Year Drug Survival 80% for Ixekizumab in Real-World Patients With Plaque Psoriasis
04/18/2023
Jolynn Tumolo
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
Monoclonal Antibody Effective in Pediatric Patients With Psoriasis
03/07/2023
Jolynn Tumolo
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic...
03/07/2023
First Report Managed Care
News
Real-World Safety of Treatment in Patients With Psoriasis Appears Comparable to Clinical Trial Reports
10/07/2022
Jolynn Tumolo
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence...
10/07/2022
First Report Managed Care
Industry Insights
News
Expert Perspectives
Commentary Podcasts Interview
FRMC Volume 22, Issue 3

Current Issue

September 2025
Volume 22
Issue 3
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use